Higher baseline TSH levels predict early hypothyroidism during cancer immunotherapy.
Cristina LuongoR MorraC GambaleT PorcelliF SessaE MatanoV DamianoM KlainM SchlumbergerD SalvatorePublished in: Journal of endocrinological investigation (2021)
Baseline TSH levels above 1.67 mIU/L and presence of Ab-T are risk factors for the development of thyroid irAEs. Patients affected by thyroid irAEs showed a longer survival than patients who remained euthyroid.